negative emotional eating _ Overweight and Obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group: People in the intervention group will receive 2 capsules of 1000 mg of pomegranate extract daily, 30 minutes before breakfast and lunch, for 8 weeks. Intervention 2
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Students over 18 years old Has a high emotional eating score of 11 (emotional eaters and extreme emotional eaters) Overweight and obesity (BMI above 25)
Exclusion criteria
Exclusion criteria: Systemic disease, including heart disease, diabetes, liver or kidney dysfunction Immune disorders smoking Drug or alcohol abuse Pregnancy and lactation Pomegranate allergy A history of weight management in the past 2 months Use of antidepressants such as SSRIs (Fluoxetine, Sertraline, etc.) Use of supplements and teas containing polyphenols and antioxidants in the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emotional Eating Questionnaire (EEQ) score: This 10-question questionnaire divides individuals into 4 groups (no emotional eating, little emotional eating, moderate emotional eating, and a lot of emotional eating) based on the score obtained. Timepoint: Questionnaires are measured at the beginning of the study (before the start of the intervention) and after 8 weeks (end of the intervention). Method of measurement: Emotional Eating Questionnaire (EEQ).;Serum cortisol concentration is an indicator of hypothalamic-pituitary-adrenal axis activity and physiological stress response, as well as a hormone that influences weight control. Timepoint: Laboratory factors are all measured at the beginning of the study (before the start of the intervention) and after 8 weeks (end of the intervention). Method of measurement: Measurement from blood sample and ELISA kit.;Malondialdehyde levels are a marker of lipid peroxidation and oxidative damage; its serum concentration indicates the severity of oxidative stress. Timepoint: Laboratory factors are all measured at the beginning of the study (before the start of the intervention) and after 8 weeks (end of the intervention). Method of measurement: Measurement from blood sample.;The antioxidant capacity of a serum sample, which indicates the ability to neutralize radicals (a general indicator of antioxidant status). Timepoint: Laboratory factors are all measured at the beginning of the study (before the start of the intervention) and after 8 weeks (end of the intervention). Method of measurement: Measurement from blood sample.;Participant self-reported feeling of Satiety. Timepoint: At the beginning of the first week and at the end of the fourth and eighth weeks of the study, we ask individuals to record their scores using a visual analog scale after consuming food and at 15-minute intervals for 60 minutes. Method of measurement: Visual Analogue Scale.;Changes in anthropometric parameters such as weight, body mass index, weight mass, | — |
Secondary
| Measure | Time frame |
|---|---|
| Three-dimensional self-assessment of symptoms of depression, anxiety, and stress. Timepoint: All questionnaires are measured and completed at the beginning of the study (before the start of the intervention) and after 8 weeks (end of the intervention). Method of measurement: DASS-21 questionnaire.;Assessing three behavioral components of eating: usually "cognitive control/self-control", "inability/out-of-control eating", and "hunger". Timepoint: All questionnaires are measured and completed at the beginning of the study (before the start of the intervention) and after 8 weeks (end of the intervention). Method of measurement: TFEQ-21 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Amir Hossein Mousavi
Ahvaz University of Medical Sciences
Outcome results
None listed